OLIVIA COOK: Open Payments
NPI 1114635638 · ARNOLD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 42 payments from 17 companies in 2025. Trend: 2023 $703 · 2024 $794 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $202 |
| Novo Nordisk Inc | 7 | $179 |
| Lilly USA, LLC | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Astellas Pharma US Inc | 2 | $61 |
| PFIZER INC. | 3 | $59 |
| Exact Sciences Corporation | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Globus Medical, Inc. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $29 |
Products named: Wegovy, MOUNJARO, VRAYLAR, Veozah, Rybelsus, AIRSUPRA, ELIQUIS, XIFAXAN.
Industry payments across MD — which companies pay providers there.
